Ex vivo activity of thalidomide in childhood acute leukemia

Leukemia and Lymphoma

Volumn 47, Issue 6, 2006, Pages 1123-1128

  Styczynski, Jan ^a   Czyzewski, Krzysztof ^a   Wysocki, Mariusz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Acute lymphoblastic leukemia; Acute myeloblastic leukemia; Cytarabine; Prednisolone; Sensitization; Thalidomide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTARABINE; PREDNISOLONE; THALIDOMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE PHASE; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG POTENCY; DRUG SENSITIZATION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOBLAST; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; CELL CYCLE; CHILD; CHILD, PRESCHOOL; CYTARABINE; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PREDNISOLONE; TETRAZOLIUM SALTS; THALIDOMIDE; THIAZOLES;

EID: 33746316471     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500467891     Document Type: Article

References (15)

1. Matthews, S and McCoy, C. (2003) Thalidomide: A review of approved and investigational uses Clin Therap, 25, pp. 342-395.
2. Yaccoby, S and Johnson, C and Mahaffey, S and Wezeman, M and Barlogie, B and Epstein, J. (2002) Antimyeloma efficacy of thalidomide in the SCID-hu model Blood, 100, pp. 4162-4168.
3. Hideshima, T and Chauhan, D and Shima, Y and Raje, N and Davies, F and Tai, Y et al. (2000) Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy Blood, 96, pp. 2943-2950.
4. Richardson, P and Schlossman, R and Weller, E and Hideshima, T and Mitsiades, C and Davies, F et al. (2002) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Blood, 100, pp. 3063-3067.
5. Mitsiades, N and Mitsiades, C and Poulaki, V and Chauhan, D and Richardson, P and Hideshima, T et al. (2002) Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications Blood, 99, pp. 4525-4530.
6. Johnston, R and Abdalla, S. (2002) Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia Leuk Lymph, 43, pp. 351-354.
7. Strupp, C and Germing, U and Aivado, M and Misgeld, E and Haas, R and Gattermann, N. (2002) Thalidomide for the treatment of patients with myelodysplastic syndromes Leukemia, 16, pp. 1-6.
8. Steins, M and Padro, T and Bieker, R and Ruiz, S and Kropff, M and Kienast, J et al. (2002) Efficacy and safety of thalidomide in patients with acute myeloid leukemia Blood, 99, pp. 834-839.
9. Dalle, J and Leblond, P and Decouvelaere, A and Yakoub-Agha, I and Preudhomme, C and Nelken, B et al. (2003) Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL Leukemia, 17, pp. 2056-2057.
10. Merup, M and Kutti, J and Birgergard, G and Mauritzson, N and Bjorkholm, M and Markevarn, B et al. (2002) Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia Med Oncol, 19, pp. 79-86.
11. Styczynski, J and Wysocki, M and Balwierz, W and Kowalczyk, J. (2002) Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin Leukemia, 16, pp. 820-825.
12. Mitsiades, N and Mitsiades, C and Poulaki, V and Chauhan, D and Richardson, P and Hideshima, T et al. (2002) Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: Therapeutic applications Blood, 99, pp. 4079-4086.
13. Munshi, N and Hideshima, T and Carrasco, D and Shammas, M and Auclair, D and Davies, F et al. (2004) Identification of genes modulated in multiple myeloma using genetically identical twin samples Blood, 103, pp. 1799-1806.
14. Miyachi, H and Azuma, A and Hioki, E and Iwasaki, S and Kobayashi, Y and Hashimoto, Y. (1996) Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production Bioch Bioph Res Com, 224, pp. 426-430.
15. El-Obeid, A and Sunnuqrut, N and Hussain, A and Al-Hussein, K and Gutierrez, M and Bhatia, K. (2004) Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR) Leukemia Res, 28, pp. 133-137.